Clinical trial

Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism

NCT02132689

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-03-01

PhasePHASE4

Study timeline

Study start (actual)2011-03-01Date precision: month

Registry last updated2018-03-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Embolismunresolved

Interventions

Actilyse (Thrombolytic therapy)DRUG

Heparine (Standard anticoagulation therapy)DRUG

Sponsors & collaborators

University Hospital Ostravalead sponsor

Municipal Hospital Ostrava Fifejdycollaborator

Silesian Hospital Opavacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02132689 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.